Documents Safety and efficacy of maraviroc in CCR5-tropic HIV-1-infected children aged 2 to

Slide 1 Safety and efficacy of maraviroc in CCR5-tropic HIV-1-infected children aged 2 to Methods Subjects infected with CCR5-tropic HIV-1 (as detected by Phenotypic assay,…